SEK 37.0
(-1.99%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 10.82 Million DKK | 5181.95% |
2022 | 205 Thousand DKK | 259.65% |
2021 | 57 Thousand DKK | -73.85% |
2020 | 218 Thousand DKK | 0.0% |
2019 | - DKK | 0.0% |
2018 | - DKK | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 10.66 Million DKK | -1.48% |
2024 Q2 | 217 Thousand DKK | -97.97% |
2023 Q2 | 193 Thousand DKK | 39.86% |
2023 Q1 | 138 Thousand DKK | -32.68% |
2023 FY | 10.82 Million DKK | 5181.95% |
2023 Q4 | 10.82 Million DKK | 5341.21% |
2023 Q3 | 199 Thousand DKK | 3.11% |
2022 Q4 | 205 Thousand DKK | -23.79% |
2022 FY | 205 Thousand DKK | 259.65% |
2022 Q2 | 333 Thousand DKK | 2278.57% |
2022 Q3 | 269 Thousand DKK | -19.22% |
2022 Q1 | 14 Thousand DKK | -75.44% |
2021 Q1 | 178 Thousand DKK | -18.35% |
2021 FY | 57 Thousand DKK | -73.85% |
2021 Q3 | 98 Thousand DKK | -28.99% |
2021 Q4 | 57 Thousand DKK | -41.84% |
2021 Q2 | 138 Thousand DKK | -22.47% |
2020 Q1 | - DKK | 0.0% |
2020 FY | 218 Thousand DKK | 0.0% |
2020 Q4 | 218 Thousand DKK | 0.0% |
2020 Q3 | - DKK | 0.0% |
2020 Q2 | - DKK | 0.0% |
2019 Q3 | - DKK | 0.0% |
2019 Q4 | - DKK | 0.0% |
2019 Q2 | - DKK | -100.0% |
2019 Q1 | 4.8 Million DKK | 0.0% |
2019 FY | - DKK | 0.0% |
2018 FY | - DKK | 0.0% |
2018 Q4 | - DKK | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
AddLife AB (publ) | 5.28 Billion SEK | 99.795% |
Biotage AB (publ) | 150 Million SEK | 92.781% |
Bonesupport Holding AB (publ) | 17.48 Million SEK | 38.069% |
Doxa AB (publ) | 9.7 Million SEK | -11.629% |
Elekta AB (publ) | 7.24 Billion SEK | 99.851% |
iZafe Group AB (publ) | 3.17 Million SEK | -241.039% |
Ortivus AB (publ) | 5.48 Million SEK | -97.555% |
Ortivus AB (publ) | 5.48 Million SEK | -97.555% |
Q-linea AB (publ) | 20.56 Million SEK | 47.347% |
S2Medical AB (publ) | - SEK | -Infinity% |
Synsam AB (publ) | 3.25 Billion SEK | 99.667% |